Company Filing History:
Years Active: 2013
Title: Olivier Chaloin: Innovator in Drug Development
Introduction
Olivier Chaloin is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of drug development, particularly through his innovative patent work. His expertise and research have positioned him as a key figure in the scientific community.
Latest Patents
Olivier Chaloin holds a patent for "Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs." This patent describes a compound of formula (I), which includes a macrocycle functionalized by three amine or COOH functions. The compound is designed to enhance drug preparation methods, showcasing Chaloin's commitment to advancing medical science.
Career Highlights
Chaloin is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research and development activities. His work has led to the creation of innovative solutions that address complex medical challenges. With a focus on drug formulation, he has contributed to the advancement of therapeutic options available to patients.
Collaborations
Olivier Chaloin has collaborated with esteemed colleagues such as Gilles Guichard and Sylvie Victorine Lucienne Fournel. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Olivier Chaloin's contributions to the field of drug development through his patent work exemplify his dedication to innovation. His research continues to influence the scientific community and improve therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.